LINC00529

Across TCGA pan-cancer cohorts, LINC00529 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated LINC00529 data layer.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher LINC00529 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC00529 expression acts as an unfavorable survival marker, although some lineages such as ESCA and HNSC show a favorable association.

LUSC, DLBC, and SKCM are the cancer types where LINC00529 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	OS	Tertile	All	0.206	0.678	<.001	144	view →
DLBC	DFS	Tertile	IV	0.125	0.744	<.001	99	view →
SKCM	OS	Tertile	III,IV	0.223	0.711	<.001	54	view →
PAAD	OS	Tertile	All	0.142	0.596	<.001	54	view →
KIRC	DFS	Tertile	IV	0.149	0.648	<.001	42	view →
READ	DFS	Tertile	All	0.112	0.845	.001	36	view →
UCS	DFS	Tertile	All	0.136	0.523	.034	18	view →
UCEC	DFS	Tertile	All	0.403	0.653	.032	12	view →
THYM	DFS	Tertile	II,III,IV	0.621	0.933	.009	9	view →
THCA	DFS	Tertile	All	0.731	0.920	.038	9	view →
STAD	DFS	Tertile	III,IV	0.325	0.634	.022	9	view →
GBM	DFS	Tertile	All	0.106	0.294	.045	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

LINC00529–LUSC (OS)

Open the LUSC breakdown →